Cristina Meseguer

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

Concepción de la Piedra, Antonio Alcaraz, Joaquim Bellmunt et al. · British Journal of Cancer · 2013 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

Antonio Alcaraz, Raquel González-López, Juan Moróte et al. · British Journal of Cancer · 2013 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial

Nicolás Roberto Robles, R. Peces, Á. Gómez-Ferrer et al. · Orphanet Journal of Rare Diseases · 2016 · 20 citations · Full text

Medicine, Pharmacotherapy, Surgery +13

Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: Results from a 2-year multicentre observational study (ZOMAR study)

Agustí Barnadas, Luís Manso, Concepción de la Piedra et al. · Bone · 2014 · 18 citations · Full text

Medicine, Oncology, Bone Metabolism +16